IP Library Granted Patent US 12,533,188
Granted Patent B2
US 12,533,188 · App. 17/113,588 · Granted Jan 27, 2026

Aesthetic laser apparatus for performing treatment by irradiating a human skin to be treated by a variable pulsed laser beam

Inventors: Shlomo Assa (Smithfield, RI); Yingyuan Fang (Smithfield, RI)
Assignee: ACCLARO CORPORATION
A61B18/20A61B2018/00452A61B2018/20351
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,533,188
App. No.
17/113,588
Granted
Jan 27, 2026
Kind
B2
Abstract

An aesthetic laser apparatus for performing treatment by irradiating a human skin to be treated by a variable pulsed laser beam is disclosed. This apparatus includes a laser source which emits variable waveform output of treatment laser beam pulses; a flexible beam delivery for delivering the treatment laser beam emitted from the laser source, the flexible beam delivery includes at the distal end automated optical scanner comprising of 2 moving mirrors; and a surgical instrument is connected to an end of the scanner and used for irradiating the treatment laser beam delivered therein to the treatment human skin. By having the ability to vary the laser's output pulse frequency, pulse width, and pulse energy, multiple tissue effects can be achieved using one laser surgical apparatus.

Claims (19)

1 . A laser surgical apparatus for performing treatment by irradiating a part to be treated by a variable pulsed laser beam comprising:

a. a laser source configured to emit optical energy at a laser wavelength in a range of 2,700 nm to 3,500 nm; and

b. a fractional optical treatment system configured to deliver an optical focused beam emitted by the laser source to a plurality of predetermined locations in a target area of soft human living tissue, the fractional optical treatment system including at least a controller, an energy calibration device, and an applicator,

wherein the controller is configured to control the laser source and the applicator to perform the treatment according to user input, the controller being configured to enable a user to select at least one of:

i. a size of the optical focused beam at a surface of the soft human living tissue,

ii. a shape of the optical focused beam at the surface of the soft human living tissue, or

iii. a pattern density of the predetermined locations in the target area,

wherein the controller is further configured to enable the user to pre-program a pulse burst having a plurality of temporally spaced-apart sub-pulses, the pulse burst being delivered to each of the plurality of predetermined locations in the target area,

the spaced-apart sub-pulses of the pulse burst comprising a plurality of ablative sub-pulses and a plurality of non-ablative sub-pulses, each of the ablative sub-pulses being temporally spaced apart from another of the ablative sub-pulses by one or more of the non-ablative sub-pulses, each of the ablative sub-pulses being identical to the other ablative sub-pulses and having a fluence between 2 to 100 Joules/cm 2 and configured to ablate the soft human living tissue, each of the non-ablative sub-pulses being identical to the other non-ablative sub-pulses and having a fluence between 0.1 to 2.0 Joules/cm 2 and configured to form a controlled localized thermal injury by depositing energy through heating the soft human living tissue without ablating the soft human living tissue,

the controller being configured to deliver the pulse burst with sufficient energy to ablate a thin layer of skin having a thickness between 10 and 200 μm, the pulse burst alternately applies an ablative sub-pulse and a non-ablative sub-pulse,

wherein the energy calibration device is configured to sample the beam emitted by the laser source and communicate with the controller in a closed loop to control energy delivered by the laser source to match energy set by the user, and

wherein the controller is further configured to optimize placement of the predetermined locations in the target area to create a predetermined energy overlap delivered in sequence.

2 . The apparatus of claim 1 , wherein the controller is configured to enable the user to select the size of the optical focused beam at a surface of the soft human living tissue.

3 . The apparatus of claim 1 , wherein the controller is configured to enable the user to select the shape of the optical focused beam at the surface of the soft human living tissue.

4 . The apparatus of claim 1 , wherein the controller is configured to enable the user to select the pattern density of the predetermined locations in the target area.

5 . The apparatus of claim 1 , wherein the plurality of predetermined locations form a ring.

6 . The apparatus of claim 5 , wherein the controller is further configured to deliver an additional laser pulse in a center of the ring to ablate soft human living tissue to a depth of between 100 and 2,000 μm.

7 . The apparatus of claim 1 , wherein the sub-pulses in the pulse burst are separated from each other by a time duration between 50 to 5,000 micro-seconds.

8 . The apparatus of claim 1 , wherein the laser source is a mid infrared fiber laser and the laser wavelength is in a range of 2,800 nm to 2,950 nm.

Assignments (2)
CHANGE OF NAME Recorded Nov 10, 2025
From: FA CORPORATION
To: ACCLARO CORPORATION
Reel/Frame 073318/0992 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2021
From: ASSA, SHLOMO; FANG, YINGYUAN
To: FA CORPORATION
Reel/Frame 058136/0353 →
Continuity (1)
Related Publication 20220175449A1 · Jun 9, 2022
References Cited (39)
US 5257706A · McIntyre · 1993 [cited by applicant]
US 5458596A · Lax · 1995 [cited by applicant]
US 5689520A · Hoang · 1997 [cited by applicant]
US 6193711B1 · Connors · 2001 [cited by applicant]
US 6277116B1 · Utely · 2001 [cited by applicant]
US 7951139B2 · Assa · 2011 [cited by applicant]
US 7957440B2 · Boutoussov · 2011 [cited by applicant]
US 8202268B1 · Wells · 2012 [cited by applicant]
US 9005262B2 · Liu · 2015 [cited by applicant]
US 9414888B2 · Liu · 2016 [cited by applicant]
US 20010016732A1 · Hobart et al. · 2001 [cited by applicant]
US 20040133190A1 · Hobart et al. · 2004 [cited by applicant]
US 20060129141A1 · Lin · 2006 [cited by applicant]
US 20080172047A1 · Altshuler · 2008 [cited by examiner]
US 20080234669A1 · Kauvar · 2008 [cited by applicant]
US 20090131922A1 · Dewey · 2009 [cited by examiner]
US 20120232537A1 · Liu et al. · 2012 [cited by applicant]
US 20130096546A1 · Mirkov · 2013 [cited by examiner]
US 20140018783A1 · Modi · 2014 [cited by examiner]
US 20140364870A1 · Alvarez et al. · 2014 [cited by applicant]
US 20150202007A1 · Manstein · 2015 [cited by examiner]
US 20170112574A1 · Cohen · 2017 [cited by examiner]
US 20180140866A1 · Daly et al. · 2018 [cited by applicant]
US 20180296269A1 · Bhawalkar · 2018 [cited by examiner]
US 20210135424A1 · Bacher · 2021 [cited by examiner]
JP 2009533197A · 2009 [cited by applicant]
JP 2019535427A · 2019 [cited by applicant]
KR 20150044772A · 2015 [cited by applicant]
WO 2010145802A1 · 2010 [cited by applicant]
WO 2011084863A2 · 2011 [cited by applicant]
WO 2022125516A1 · 2022 [cited by applicant]
Lukac et al., “Dual Tissue Regeneration: Non-Ablative Resurfacing of Soft tissues with FotonaSmooth Mode Er:YAG Laser”, 2018, Journal of Laser and Health Academy (Year: 2018). [cited by examiner]
Complications of carbon dioxide laser resurfacing. An evaluation of 500 patients C A Nanni 1 , T S Alster. [cited by applicant]
Nanni et al., “Complications of carbon dioxide laser resurfacing, An evaluation of 500 paitents” American Society for Dermatol Surg, 24, pp. 315-320, 1998. [cited by applicant]
Int'l Search Report and Written Opinion issued Mar. 18, 2022 in Int'l Application No. PCT/US21/63497. [cited by applicant]
Int'l Search Report and Written Opinion issued Feb. 23, 2022 in Int'l Application No. PCT/US21/62159. [cited by applicant]
Extended European Search Report issued Jul. 23, 2024 in European Application No. 21904228.0. [cited by applicant]
Office Action issued Jul. 29, 2024 in U.S. Appl. No. 17/073,524. [cited by applicant]
Partial European Search Report issued Jun. 18, 2024 in European Application No. 21884077.5. [cited by applicant]